Tech Company Financing Transactions
NeuroMolecular Pharmaceuticals Funding Round
NeuroMolecular Pharmaceuticals closed a $8.7 million venture capital round on 6/30/2005. Backers included Mohr Davidow Ventures and private investors.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$8,685,000
Round
Undisclosed
Investors
Mohr Davidow Ventures (William Ericson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1900 Powell Street 1050
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Went
Vice President
Gans Ganapati
Vice President
Efraim Shek
VP - Bus. Development
Peter Hadrovic
VP - R & D
Amy Patick
Browse more venture capital transactions:
Prev: 6/30/2005: RealOps venture capital transaction
Next: 6/30/2005: DAFCA venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs